Comment on: ‘Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'

Detalles Bibliográficos
Autores principales: Vivaldi, Caterina, Fornaro, Lorenzo, Caparello, Chiara, Falcone, Alfredo, Vasile, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891507/
https://www.ncbi.nlm.nih.gov/pubmed/27124336
http://dx.doi.org/10.1038/bjc.2016.69
_version_ 1782435274273325056
author Vivaldi, Caterina
Fornaro, Lorenzo
Caparello, Chiara
Falcone, Alfredo
Vasile, Enrico
author_facet Vivaldi, Caterina
Fornaro, Lorenzo
Caparello, Chiara
Falcone, Alfredo
Vasile, Enrico
author_sort Vivaldi, Caterina
collection PubMed
description
format Online
Article
Text
id pubmed-4891507
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-48915072016-06-10 Comment on: ‘Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort' Vivaldi, Caterina Fornaro, Lorenzo Caparello, Chiara Falcone, Alfredo Vasile, Enrico Br J Cancer Letter to the Editor Nature Publishing Group 2016-05-24 2016-04-28 /pmc/articles/PMC4891507/ /pubmed/27124336 http://dx.doi.org/10.1038/bjc.2016.69 Text en Copyright © 2016 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ This work is licensed under the Creative Commons Attribution-Non-Commercial-Share Alike 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
spellingShingle Letter to the Editor
Vivaldi, Caterina
Fornaro, Lorenzo
Caparello, Chiara
Falcone, Alfredo
Vasile, Enrico
Comment on: ‘Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'
title Comment on: ‘Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'
title_full Comment on: ‘Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'
title_fullStr Comment on: ‘Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'
title_full_unstemmed Comment on: ‘Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'
title_short Comment on: ‘Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'
title_sort comment on: ‘nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after folfirinox failure: an ageo prospective multicentre cohort'
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891507/
https://www.ncbi.nlm.nih.gov/pubmed/27124336
http://dx.doi.org/10.1038/bjc.2016.69
work_keys_str_mv AT vivaldicaterina commentonnabpaclitaxelplusgemcitabineformetastaticpancreaticadenocarcinomaafterfolfirinoxfailureanageoprospectivemulticentrecohort
AT fornarolorenzo commentonnabpaclitaxelplusgemcitabineformetastaticpancreaticadenocarcinomaafterfolfirinoxfailureanageoprospectivemulticentrecohort
AT caparellochiara commentonnabpaclitaxelplusgemcitabineformetastaticpancreaticadenocarcinomaafterfolfirinoxfailureanageoprospectivemulticentrecohort
AT falconealfredo commentonnabpaclitaxelplusgemcitabineformetastaticpancreaticadenocarcinomaafterfolfirinoxfailureanageoprospectivemulticentrecohort
AT vasileenrico commentonnabpaclitaxelplusgemcitabineformetastaticpancreaticadenocarcinomaafterfolfirinoxfailureanageoprospectivemulticentrecohort

Ejemplares similares